Relationship between Clozapine-Induced Electroencephalogram Abnormalities and Serum Concentration of Clozapine in Japanese Patients with Treatment-Resistant Schizophrenia
Yuka Sugawara Kikuchi, Takashi Kanbayashi, Tetsuo Shimizu
Psychiatry Investig. 2019;16(4):279-284.   Published online 2019 Apr 8     DOI: https://doi.org/10.30773/pi.2018.12.16
The relationship between plasma clozapine concentration and clinical outcome: a cross‐sectional study
Yuji Yada, Kohei Kitagawa, Shinji Sakamoto, Atsushi Ozawa, Akihiro Nakada, Hiroko Kashiwagi, Yuko Okahisa, Soshi Takao, Manabu Takaki, Yoshiki Kishi, Norihito Yamada
Acta Psychiatrica Scandinavica.2021; 143(3): 227.     CrossRef
Development of a simultaneous analytical method for clozapine and its metabolites in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry with linear range adjusted by in‐source collision‐induced dissociation
Toshihiro Sato, Masato Suzuka, Yuji Sato, Riko Iwabuchi, Daisuke Kobayashi, Jiro Ogura, Shinya Takasaki, Maki Yokota, Taku Tsukamoto, Yoshihiro Hayakawa, Masafumi Kikuchi, Masamitsu Maekawa, Nariyasu Mano
Biomedical Chromatography.2021;[Epub]     CrossRef
Risk factors for clozapine-induced central nervous system abnormalities in Japanese patients with treatment-resistant schizophrenia
Kohei Kitagawa, Shusuke Uekusa, Kazuhiro Matsuo, Kei Moriyama, Tatsuro Yamamoto, Yuji Yada, Masafumi Kodama, Yoshiki Kishi, Takashi Yoshio
Asian Journal of Psychiatry.2021; 60: 102652.     CrossRef
Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics
Jose de Leon
Neuropharmacology.2020; 168: 107656.     CrossRef